High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas.
Philip D TatmanTadeusz H WroblewskiAnthony R FringuelloSamuel R SchererWilliam B ForemanDenise M DamekKevin LilleheiA Samy YoussefRandy L JensenMichael W GranerD Ryan OrmondPublished in: Journal of clinical medicine (2021)
These findings strongly suggest an important role of HDACs in meningioma biology and as a targetable mechanism. Additional validation studies are necessary to confirm these promising findings, as well to identify an ideal HDAC inhibitor candidate to develop for clinical use.